Evolent Health Inc Class A (EVH)

Cost of Revenue

$1.83B

TTM · Period ending: · USD

EVH logo

EVH Cost of Revenue

Latest reported$1.83B
EVH TTM Cost of Revenue ($14.82M → $1.83B)
High-resolution chart · PNG

EVH cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Evolent Health Inc Class A Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
1,826,188,000
1,621,888,000
1,568,739,000
1,723,067,000
1,860,101,000
2,033,019,000
2,187,388,000
2,070,985,000
1,916,862,000
1,728,498,000
1,503,426,000
1,348,366,000
1,228,398,000
1,126,165,000
1,035,429,000
900,541,000
797,050,000
719,458,000
657,551,000
669,814,000
688,449,000
680,694,000
698,491,000
677,220,000
627,222,000
571,247,000
513,059,000
470,423,000
412,627,000
373,247,000
327,781,000
280,494,000
274,808,000
273,799,000
269,352,000
263,686,000
229,310,000
194,095,000
155,129,000
119,995,000
110,852,000
85,960,000
83,852,000
59,103,000
34,341,000
26,454,000
14,821,000
15,914,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.